Rin GTPase And Dopamine Transporter Trafficking: Linking Mechanisms To Behavior

Rin GTP 酶和多巴胺转运蛋白贩运:将机制与行为联系起来

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Dopamine (DA) signaling in the CNS is essential for modulating complex behaviors such as movement, cognition, reward, and motivation. Aberrant DAergic transmission is directly linked to Parkinson's disease, attention-deficit hyperactivity disorder, schizophrenia and addiction. The plasma membrane dopamine transporter (DAT) is central to DAergic signaling, and both limits extracellular DA availability and maintains presynaptic DA stores. Importantly, DAT is the primary target for both addictive and therapeutic psychoactive drugs, such as cocaine, amphetamine, methylphenidate (Ritalin), and the antidepressant bupropion (Wellbutrin), all of which competitively inhibit DAT activity. A wealth of data supports the premise that DAT constitutively traffics to and from the cell surface, and that protein kinase C (PKC) activation rapidly decreases DAT cell surface expression by acutely modulating DAT trafficking rates. While some progress has been made investigating the molecular mechanisms that govern regulated DAT trafficking, a detailed understanding of this complex process has yet to be achieved. Further, the physiological relevance that DAT trafficking imposes onto DAergic function is poorly understood. Our laboratory reported that neuronal GTPase, Rin (RIT2), specifically binds to the DAT carboxy terminus and is required for PKC-stimulated DAT internalization. In the proposed studies, I plan to investigate the molecular underpinnings required for DAT/Rin interactions, and how these interactions potentially mediate synergy between cytosolic DAT domains. Aim 1 studies will use co-immunoprecipitations and FRET microscopy approaches with chimeric DAT proteins to define the intracellular DAT domains that are necessary and sufficient to confer DAT/Rin interactions. Chimeric and point mutant transporters will further reveal the potential synergistic requirement of DAT amino- and carboxy-termini for PKC-stimulated DAT internalization. Aim 2 studies will directly test the potential role of Rin-mediated DAT trafficking in DAergic behaviors in vivo, using cell-specific, AAV2-mediated Rin knockdown in DAergic terminal regions. Taken together, these studies will provide the first investigations that directly examine how DAT trafficking potentially impacts rewarding behavior. Moreover, completion of this investigative line will provide me with outstanding training in molecular and behavioral neuroscience.
 描述(由申请人提供):中枢神经系统中的多巴胺(DA)信号对于调节复杂的行为,如运动、认知、奖励和动机是必不可少的。异常的多巴能传递与帕金森氏症、注意力缺陷多动障碍、精神分裂症和成瘾直接相关。质膜多巴胺转运体(DAT)是DA能信号转运体的中枢,既限制细胞外DA的可获得性,又维持突触前DA的储存。重要的是,DAT是成瘾和治疗精神活性药物的主要靶点,如可卡因、苯丙胺、哌甲酸甲酯(利他林)和抗抑郁剂安非他酮(Wellbutrin),所有这些都竞争性地抑制DAT的活性。一大笔钱 数据支持这一假设,即DAT在细胞表面的往返运输是结构性的,而蛋白激酶C(PKC)的激活通过剧烈地调节DAT的运输速率而迅速减少DAT细胞表面的表达。虽然已在研究管理受管制的DAT贩运的分子机制方面取得了一些进展,但对这一复杂过程的详细了解尚未实现。此外,DAT贩运对DAR能功能施加的生理相关性还知之甚少。我们的实验室报道了神经元GTP酶Rin(RIT2)特异性地结合到DAT的羧基末端,并且是PKC刺激的DAT内化所必需的。在拟议的研究中,我计划研究DAT/Rin相互作用所需的分子基础,以及这些相互作用如何潜在地调节胞质DAT结构域之间的协同作用。目的1研究将使用免疫共沉淀和FRET显微镜方法与嵌合的DAT蛋白来确定细胞内的DAT结构域,这些结构域是实现DAT/Rin相互作用的必要条件和充分条件。嵌合和点突变转运蛋白将进一步揭示DAT氨基和羧基末端对PKC刺激的DAT内化的潜在协同需求。目的2项研究将利用细胞特异性的、AAV2介导的DAR能终末区域敲除Rin,直接测试Rin介导的DAT转运在体内DAR能行为中的潜在作用。综上所述,这些研究将提供第一次调查,直接检查DAT贩运如何潜在地影响奖励行为。此外,这条研究路线的完成将为我提供分子和行为神经科学方面的出色培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carolyn Gray Sweeney其他文献

Carolyn Gray Sweeney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carolyn Gray Sweeney', 18)}}的其他基金

Serotonin Regulation of VIP Interneurons and Auditory Learning
VIP 中间神经元的血清素调节和听觉学习
  • 批准号:
    10011558
  • 财政年份:
    2019
  • 资助金额:
    $ 3.02万
  • 项目类别:
Serotonin Regulation of VIP Interneurons and Auditory Learning
VIP 中间神经元的血清素调节和听觉学习
  • 批准号:
    10244937
  • 财政年份:
    2019
  • 资助金额:
    $ 3.02万
  • 项目类别:
Serotonin Regulation of VIP Interneurons and Auditory Learning
VIP 中间神经元的血清素调节和听觉学习
  • 批准号:
    10402662
  • 财政年份:
    2019
  • 资助金额:
    $ 3.02万
  • 项目类别:
Rin GTPase And Dopamine Transporter Trafficking: Linking Mechanisms To Behavior
Rin GTP 酶和多巴胺转运蛋白贩运:将机制与行为联系起来
  • 批准号:
    9267953
  • 财政年份:
    2015
  • 资助金额:
    $ 3.02万
  • 项目类别:
Rin GTPase And Dopamine Transporter Trafficking: Linking Mechanisms To Behavior
Rin GTP 酶和多巴胺转运蛋白贩运:将机制与行为联系起来
  • 批准号:
    8903446
  • 财政年份:
    2015
  • 资助金额:
    $ 3.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了